A favorable metabolic and antiatherogenic profile in carriers of CYP21A2 gene mutations supports the theory of a survival advantage in this population. (Q43257991)
Jump to navigation
Jump to search
scientific article published on 21 October 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A favorable metabolic and antiatherogenic profile in carriers of CYP21A2 gene mutations supports the theory of a survival advantage in this population. |
scientific article published on 21 October 2009 |
Statements
A favorable metabolic and antiatherogenic profile in carriers of CYP21A2 gene mutations supports the theory of a survival advantage in this population (English)
George P Chrousos
Maria Dracopoulou
Christina Lazaropoulou
Ioannis Papassotiriou
Amalia Sertedaki
G Nick Angelopoulos
Catherine Dacou-Voutetakis
21 October 2009